Christian Stehlik
- Cedars-Sinai Medical Center · Pathology (investigator's affiliation)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #13,908
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 7844834Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-3782-2484Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$1.4M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#13,908
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Christian Stehlik as a PI. Multi-PI records show the full award amount for context.
- 5R01DK143393-02R01Contact PIPOP3 regulates type I interferon and ameliorates intestinal inflammationCedars-Sinai Medical Center · Pathology (investigator's affiliation)$758.5Kaward amount
- 1R01CA301129-01A1R01Co-investigatorA novel protective role of PYDC5 in colorectal cancerCedars-Sinai Medical Center · Pathology (investigator's affiliation)$679.4Kaward amount
Award organization
Organizations that administered FY2026 awards listing Christian Stehlik as a PI.
FY2026 award administered by Cedars-Sinai Medical Center (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardCedars-Sinai Medical Center
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #5352
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Christian Stehlik.